Abstract
Pharmacopoeia encompasses a wide spectrum of molecules known to have a photosensitizing effect.1 Both experimental and epidemiologic studies suggest that photosensitizing drugs, especially antihypertensive agents, may influence the incidence of skin cancer.2,3 The objective of our study was to investigate a possible association between the intake of photosensitizing drugs and Breslow thickness (BT) among melanoma patients. The study was retrospectively performed at inpatient wards of melanoma units from 2 different hospitals: IDI-IRCCS in Rome and University Hospital Sant’Orsola-Malpighi in Bologna, Italy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
